AstraZeneca Loses Bid To Overturn Prilosec Ruling
The U.S. Court of Appeals for the Federal Circuit has upheld a lower court ruling that Mylan Laboratories Inc.'s generic version of the gastric-acid inhibitor Prilosec does not infringe rival AstraZeneca...To view the full article, register now.
Already a subscriber? Click here to view full article